-
May 7: Leveraging Real World Evidence to Support Patient Safety Monitoring After Clinical Trials - In Person at ISPOR 2023
-
May 7: Core Concepts and Approaches to Early-Stage Health Technology Assessment - In Person at ISPOR 2023
-
May 7: Case Studies in Pharmaceutical/Biotech Pricing II - In Person at ISPOR 2023
-
May 7: Advanced Decision Modeling for Health Economic Evaluations - In Person at ISPOR 2023
-
May 24-25: Payment for Pharmaceuticals in the US—Understanding the Healthcare System(TM)- Virtual
-
ISPOR 2023 - Digital Conference Pass
NEW this year is the ISPOR 2023 Digital Conference Pass that provides registrants with access to valuable on-demand content from the conference. The Digital Conference Pass includes on-demand recordings of the educational content from ISPOR 2023, in addition to a post-conference Key Insights Session that will provide highlights and commentary on the conference content and activities.
-
Clinical Trial Innovation: How Healthcare Technology is Evolving
-
Challenges in Rare Disease Diagnostics: An Overview
-
June 6-7: Pharmacoeconomic Modeling-Applications- Virtual
-
Assessment of Digital Health Technologies in the Asia Pacific Region
-
FDA Patient-Focused Drug Development (PFDD) Guidance - Part 3
-
June 28-29: Valuing Health: The Generalized Risk Adjusted Cost Effectiveness (GRACE) Model- Virtual
-
Assessing Causal Treatment Effect for Sequenced Oncology Regimens
-
July 19: Learning and Applying Discrete Event Simulation- Virtual
-
Economic Evaluation of Digital Health Technologies
-
July 25-26: Model Calibration in R- Virtual
-
Health is Wealth
-
August 7-8: Economic Model Review: Quality Control, Strategic Assessment and Reporting Standards- Virtual
-
August 22-23: Selecting Rapid Review Methods for Health Technology Assessment- Virtual
-
Driving Health Outcomes: Exploring Value-Based Procurement